Canna~Fangled Abstracts Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists As Potential Treatment for Inflammatory Kidney Diseases. 2015 Jul 21. doi: 10.1002/cmdc.201500218. Nettekoven M1, Adam JM2, Bendels S2, Bissantz C2, Fingerle J3, Grether U2, Grüner S3, Guba W2, Kimbara A2, Ottaviani…Freedom WaresJuly 21, 2015
Canna~Fangled Abstracts CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120. CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120. Hu S, Sheng WS, Rock…Freedom WaresOctober 23, 2013
Canna~Fangled Abstracts WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Eur J Neurosci. Author manuscript; available in PMC 2009 October 2. Published in final edited…Freedom WaresAugust 17, 2013
Canna~Fangled Abstracts Different Classes of CB2 Ligands Potentially Useful in the Treatment of Pain. 2013 Apr;8(1):42-69. Different classes of CB2 ligands potentially useful in the treatment of pain. Murineddu…Freedom WaresApril 17, 2013
Canna~Fangled Abstracts Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55. 2012 Nov 14;4(1):41-5. doi: 10.1021/ml300235q. eCollection 2013. Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors…Freedom WaresNovember 7, 2012